|
Market Closed -
Swiss Exchange
11:30:15 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 0.0208 CHF | -7.96% |
|
-7.96% | -62.45% |
| 10-08 | Swiss Market Index Retreats; Novartis Shares Decline | MT |
| 10-08 | Addex Therapeutics' Neurosterix to Advance Schizophrenia Drug to Phase 2 Trials | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 5.59M | - | - | - | - | - |
| 65.94B | |||||
| 56.53B | |||||
| 56.88B | |||||
| 46.49B | |||||
| 44.8B |
Select your edition
All financial news and data tailored to specific country editions
